BACKGROUND: The matrix component in autologous chondrocyte implantation plays an important role. In this study the influence of an additional fibrin component in cartilage constructs based on polyglycolide polymers (PGA) was investigated. METHODS: Human chondrocytes of femoral heads were isolated and cultured using a serum-free technique. The cells were seeded on PGA-91 scaffolds with and without an additional fibrin component; the constructs were cultured for 2 weeks in vitro. Besides cell viability, DNA content, pH, aggrecan production, mRNA expression of aggrecan, and collagen types I and II were determined by real-time PCR. Furthermore, cartilage grafts were histologically analyzed. RESULTS: All constructs contained viable, metabolically active cells in the investigated time period. There was no cell proliferation within the graft, and the DNA content was decreased over time. The pH level constantly remained within a physiologic range. The Alcian blue staining of the constructs showed the homogeneous cell distribution and a cell-associated proteoglycan production. Aggrecan concentration in the supernatants of fibrin-containing constructs was significantly lower compared to fibrin-free grafts (-24%), a result that correlated with diminished aggrecan mRNA expression (-80%). mRNA expression of collagen type II increased in the fibrin-free constructs over time and was 57% higher than in the fibrin-containing grafts. The immunohistochemical detection of collagen type II was possible in all constructs. CONCLUSION: Cartilage constructs based on carbohydrate matrices are suitable for matrix-associated chondrocyte implantation. The results of this study suggest a partially inhibitory effect of an additional fibrin component in PGA constructs for chondrogenic differentiation.
BACKGROUND: The matrix component in autologous chondrocyte implantation plays an important role. In this study the influence of an additional fibrin component in cartilage constructs based on polyglycolide polymers (PGA) was investigated. METHODS:Human chondrocytes of femoral heads were isolated and cultured using a serum-free technique. The cells were seeded on PGA-91 scaffolds with and without an additional fibrin component; the constructs were cultured for 2 weeks in vitro. Besides cell viability, DNA content, pH, aggrecan production, mRNA expression of aggrecan, and collagen types I and II were determined by real-time PCR. Furthermore, cartilage grafts were histologically analyzed. RESULTS: All constructs contained viable, metabolically active cells in the investigated time period. There was no cell proliferation within the graft, and the DNA content was decreased over time. The pH level constantly remained within a physiologic range. The Alcian blue staining of the constructs showed the homogeneous cell distribution and a cell-associated proteoglycan production. Aggrecan concentration in the supernatants of fibrin-containing constructs was significantly lower compared to fibrin-free grafts (-24%), a result that correlated with diminished aggrecan mRNA expression (-80%). mRNA expression of collagen type II increased in the fibrin-free constructs over time and was 57% higher than in the fibrin-containing grafts. The immunohistochemical detection of collagen type II was possible in all constructs. CONCLUSION:Cartilage constructs based on carbohydrate matrices are suitable for matrix-associated chondrocyte implantation. The results of this study suggest a partially inhibitory effect of an additional fibrin component in PGA constructs for chondrogenic differentiation.
Authors: C Andree; M Voigt; A Wenger; T Erichsen; K Bittner; D Schaefer; K J Walgenbach; J Borges; R E Horch; E Eriksson; G B Stark Journal: Tissue Eng Date: 2001-12
Authors: H Schmal; J Zwingmann; M Fehrenbach; G Finkenzeller; G B Stark; N P Südkamp; D Hartl; A T Mehlhorn Journal: Cytotherapy Date: 2007 Impact factor: 5.414
Authors: M Endres; K Neumann; S E A Schröder; S Vetterlein; L Morawietz; J Ringe; M Sittinger; C Kaps Journal: Tissue Cell Date: 2007-08-03 Impact factor: 2.466
Authors: M Sittinger; D Reitzel; M Dauner; H Hierlemann; C Hammer; E Kastenbauer; H Planck; G R Burmester; J Bujia Journal: J Biomed Mater Res Date: 1996
Authors: A Lohan; U Marzahn; K El Sayed; A Haisch; B Kohl; R D Müller; W Ertel; G Schulze-Tanzil; T John Journal: Histochem Cell Biol Date: 2011-06-09 Impact factor: 4.304
Authors: Lisa E Freed; George C Engelmayr; Jeffrey T Borenstein; Franklin T Moutos; Farshid Guilak Journal: Adv Mater Date: 2009-09-04 Impact factor: 30.849